Alembic Pharmaceuticals informs about updates

11 Dec 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-II Facilty at Panelav for its 8 APIs. The inspection was conducted from 16th September, 2024 to 20th September, 2024.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1056.00 20.25 (1.96%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.